How to Talk to Your Family About Ketamine Therapy

Deciding to start ketamine therapy is one decision. Figuring out how to talk to your family about it is often the harder one. Ketamine carries a stigma that most antidepressants do not: recreational associations, unfamiliar terminology, and general discomfort with anything that sounds unconventional. If you are anticipating judgment, worry, or outright opposition from people close to you, you are not alone, and there is a way to have this conversation that invites understanding instead of conflict.

This guide covers who actually needs to know, how to prepare your reasoning, how to frame the conversation using accurate medical language, and how to respond to the objections family members commonly raise about ketamine therapy. You are not obligated to disclose your medical treatment to anyone, but for people who share your home, drive you to appointments, or support your recovery, an honest conversation usually works better than secrecy.

Who Actually Needs to Know

Some people are close enough to your daily life that keeping ketamine therapy secret usually creates more problems than it solves. Other relationships are optional to disclose, and some people probably do not need clinical detail at all. Base the decision on who is directly involved in your daily life, care, or recovery, not on who might find out anyway.

People who need to know

• Your spouse or partner. If you share a household, they will likely notice your treatment schedule and how you feel after sessions.
• Your treatment companion. Whoever drives you to appointments and stays with you afterward needs to understand what they are supporting. Our first appointment checklist covers what this role typically involves.
• Household members. Anyone living with you should know enough to understand why you may seem different on treatment days.

People who might benefit from knowing

• Parents, if you already have a close relationship and they know about your mental health history.
• Siblings who are already part of your support network.
• Adult children, especially if they have noticed your depression or pain and worry about you.
• Close friends who function as chosen family.

People who probably do not need to know

• Extended family who are not closely involved in your daily life.
• Relatives with a history of judgment or gossip. Protecting your privacy is not dishonest, it is reasonable.
• Very young children, who do not need clinical detail. If they ask questions, simple, age-appropriate answers are enough.

You are under no legal or medical obligation to disclose ketamine therapy to anyone.

How to Frame the Conversation

Lead with your experience, not the treatment name

Start with what your family member already knows: your struggle. Rather than opening with "I've decided to start ketamine therapy," try something like: "You know I've been struggling with depression for a long time. I've tried several treatments and none of them worked well enough. My doctor and I have been discussing an option with strong evidence for people who haven't responded to standard antidepressants, and I've decided to try it. It's called ketamine therapy." This framing puts the focus on your ongoing struggle and the medical rationale, not on a word that might trigger an immediate reaction.

Acknowledge the stigma directly

Do not pretend the stigma does not exist. Naming it first often prevents your family member from feeling like they have to raise it themselves: "I know ketamine might sound surprising. Most people associate it with recreational use or anesthesia. But research over the past two decades has shown that at low, carefully monitored doses, it's one of the more studied options for depression that hasn't responded to standard medications." According to the National Institute of Mental Health, esketamine (Spravato) and ketamine are being used and studied as rapid-acting options for depression that has not responded to standard antidepressant treatment. The FDA (U.S. Food and Drug Administration), the federal agency that reviews and approves medical treatments for safety and effectivenessapproved the esketamine nasal spray Spravato in March 2019 for treatment-resistant depression, a fact worth citing directly if a family member questions whether ketamine-based treatment has any regulatory recognition at all.

Use accurate medical language

Precise language helps normalize the conversation without being dishonest:

• "My provider is prescribing a treatment," instead of "I'm going to take ketamine."
• "The protocol involves a series of monitored sessions," instead of describing it informally.
• "It works on the glutamate system in the brain," instead of focusing on the subjective experience. Glutamate is the brain's primary excitatory neurotransmitter, and researchers believe ketamine's effect on this system is part of why it can act faster than traditional antidepressants.
• "It's administered under medical supervision with vital sign monitoring."

If a family member wants more detail on how ketamine compares to the nasal spray version, our ketamine vs. esketamine guide breaks down the differences in plain language.

Be specific about safety

Family members worried about safety respond better to specifics than reassurance alone:

• "My provider monitors my blood pressure, heart rate, and oxygen levels throughout every session."
• "I had a full medical evaluation before being approved for treatment."
• "The doses used for depression are far lower than anesthetic or recreational doses."
• "I have a companion with me during and after every session."

For a fuller breakdown of what to expect and monitor for, see our side effects and safety guide.

Handling Common Objections

Even a well-prepared conversation can run into pushback. Family members tend to raise the same handful of concerns. Responding calmly, with specifics rather than defensiveness, tends to matter more than the exact words you choose.

"Isn't that just a party drug?"

Ketamine has a documented history of recreational misuse, and that history is part of why the stigma exists. It is also true that ketamine is a Schedule III controlled substance under the federal Controlled Substances Act, meaning it has recognized medical uses alongside a potential for misuse. That is a different fact from what happens in a clinical setting. The doses used for depression treatment are a fraction of anesthetic or recreational doses, administered by a licensed provider who evaluates you beforehand and monitors you throughout the session. The FDA's approval of Spravato is one concrete example of the same drug class having an established, regulated place in mental health treatment.

"Won't you get addicted?"

This is a fair question to take seriously rather than dismiss. Ketamine used outside medical supervision, at high or frequent doses, carries a risk of misuse, which is part of why regulators classify it as a controlled substance. In a clinical setting, treatment is time-limited, doses are lower, sessions are spaced out, and your provider tracks your response over time. If a family member remains concerned, our discontinuation guide lays out what is known about stopping treatment.

"Why can't you just try harder, or try another antidepressant?"

This objection often comes from not understanding what treatment-resistant depression means. If it applies to you, explain that you tried other antidepressants first and they did not work well enough, and that ketamine therapy is generally used after standard options have already been tried. You can note that NIMH and other researchers specifically study ketamine and esketamine as options for people whose depression has not responded to standard antidepressant treatment, not as a replacement for talk therapy or first-line medication.

"Is this even legal or approved?"

Esketamine, sold as Spravato, is FDA-approved for treatment-resistant depression. Ketamine itself is FDA-approved as an anesthetic and is prescribed off-label for depression and other conditions, a common and legal practice in medicine where a licensed provider prescribes an approved drug for a use outside its original FDA approval. Our ketamine vs. esketamine comparison explains the difference between the two in more detail.

"What if something goes wrong during a session?"

This is where specifics about your provider's protocol matter most. Explain what evaluation you went through before approval, what monitoring happens during sessions, and who is present. If you have not asked your provider these questions yourself yet, our guide to questions to ask a ketamine provider can help you gather answers before you have this conversation with family.

"How much does this cost, and is it covered by insurance?"

Cost is a legitimate practical concern, especially if a family member helps manage household finances. Insurance coverage for ketamine therapy varies by provider, treatment type, and diagnosis. Our insurance coverage guide walks through what is typically covered, what is not, and how to ask your provider about cost before you commit to a course of treatment.